Last Updated: August 3, 2026

Litigation Details for MSP Recovery Claims Series LLC v. Amgen, Inc. (S.D. Fla. 2020)

✉ Email this page to a colleague

« Back to Dashboard

MSP Recovery Claims Series LLC v. Amgen, Inc. (S.D. Fla. 2020)

Docket	⤷ Start Trial	Date Filed	2020-02-06
Court	District Court, S.D. Florida	Date Terminated	2020-02-28
Cause	28:1331 Fed. Question: Anti-trust	Assigned To	Federico A. Moreno
Jury Demand	Plaintiff	Referred To
Patents	6,011,068; 6,211,244; 6,313,146; 7,829,595; 9,375,405
Link to Docket	External link to docket

Small Molecule Drugs cited in MSP Recovery Claims Series LLC v. Amgen, Inc.

The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .

Details for MSP Recovery Claims Series LLC v. Amgen, Inc. (S.D. Fla. 2020)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2020-02-06				External link to document
2020-02-05	1		One of Amgen’s patents for Sensipar, U.S. Patent No. 6,011,068 (the “’068 Patent”), was set to expire…2016); 6,313,146 (expired December 14, 2016); 6,011,068 (expired March 8, 2018); 7,829,595 (set to …certifications against the patents covering Sensipar. Among these patents was U.S. Patent No. 9,375,405 (the….” Unlike the ’086 patent, the ’405 Patent was a formulation patent, and only covered a new formulation… with the primary substance patent being the ’068 patent. These patents were originally assigned by	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.